4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)

4:4 阿片类药物暴露和神经发育的调查 (iOPEN)

基本信息

  • 批准号:
    10321798
  • 负责人:
  • 金额:
    $ 22.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-30 至 2021-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The SARS-CoV-2 (COVID-19) pandemic represents the most significant environmental event in living history. Sixty-eight million people worldwide have fallen ill to this disease, and 1.5 million people have died. Amongst those at greatest risk are society’s most vulnerable populations, including pregnant women and their children. It is unclear whether and how COVID-19 illness during pregnancy impacts the development of the child, as well as whether the timing of illness has any influence over this effect. It is also unknown whether environmental factors may mitigate observed outcomes. The present study will examine neurobehavioral trajectories in 100 children, half of whom will be born to women with COVID-19 infection diagnoses during pregnancy. Infants will undergo prospective longitudinal assessments at 1-, 6-, 9- and 12-months, including MRI 1 month (N = 50) and 12 months (N = 100). Our central hypotheses are that (1) perinatal COVID-19 leads to differences in infant attention, affect, myelination, and systems-level neural functional connectivity and that (2) earlier timing of prenatal infection and illness severity increase risk for developmental delay. We will explore specific environmental factors with potential influence over the association between maternal prenatal COVID-19 infection and child outcomes, particularly pre- and postnatal psychological health and partner support. We will thus be able to meaningfully evaluate whether, and how, prenatal COVID-19 illness modifies neurobehavioral development of infants and will address how variation in maternal psychobiological health influences observed associations.
项目概要 SARS-CoV-2 (COVID-19) 大流行是人类历史上最重大的环境事件。 全世界有 6800 万人患上这种疾病,150 万人死亡。其中 面临最大风险的是社会最弱势群体,包括孕妇及其子女。 目前尚不清楚怀孕期间的 COVID-19 疾病是否以及如何影响孩子的发育 患病时间是否对这种效果有影响。环境是否也未知 因素可能会减轻观察到的结果。本研究将检查 100 人的神经行为轨迹 儿童,其中一半是在怀孕期间诊断出感染了 COVID-19 的妇女所生的。婴儿会 在 1、6、9 和 12 个月时进行前瞻性纵向评估,包括 1 个月的 MRI (N = 50) 和 12 个月(N = 100)。我们的中心假设是 (1) 围产期 COVID-19 导致婴儿的差异 注意力、情感、髓鞘形成和系统级神经功能连接,以及 (2) 较早的时间 产前感染和疾病严重程度会增加发育迟缓的风险。我们将探讨具体 对孕产妇产前 COVID-19 之间的关联具有潜在影响的环境因素 感染和儿童结局,特别是产前和产后心理健康和伴侣支持。我们将 因此能够有意义地评估产前 COVID-19 疾病是否以及如何改变神经行为 婴儿的发育,并将解决观察到的母亲心理生物学健康变化如何影响的问题 协会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Veerle Bergink其他文献

Veerle Bergink的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Veerle Bergink', 18)}}的其他基金

The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
产前母体感染和炎症对青春期人脑发育和精神病理学的影响
  • 批准号:
    10296635
  • 财政年份:
    2021
  • 资助金额:
    $ 22.89万
  • 项目类别:
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
产前母体感染和炎症对青春期人脑发育和精神病理学的影响
  • 批准号:
    10640239
  • 财政年份:
    2021
  • 资助金额:
    $ 22.89万
  • 项目类别:
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
产前母体感染和炎症对青春期人脑发育和精神病理学的影响
  • 批准号:
    10468261
  • 财政年份:
    2021
  • 资助金额:
    $ 22.89万
  • 项目类别:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
  • 批准号:
    10569044
  • 财政年份:
    2020
  • 资助金额:
    $ 22.89万
  • 项目类别:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
  • 批准号:
    10117285
  • 财政年份:
    2020
  • 资助金额:
    $ 22.89万
  • 项目类别:
EXPOSURE TO TETRACYCLINE ANTIBIOTICS AND THE POTENTIAL PROTECTIVE EFFECT ON SCHIZOPHRENIA RISK.
接触四环素抗生素及其对精神分裂症风险的潜在保护作用。
  • 批准号:
    10039207
  • 财政年份:
    2020
  • 资助金额:
    $ 22.89万
  • 项目类别:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
  • 批准号:
    10334499
  • 财政年份:
    2020
  • 资助金额:
    $ 22.89万
  • 项目类别:
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
4:4 阿片类药物暴露和神经发育的调查 (iOPEN)
  • 批准号:
    9899554
  • 财政年份:
    2019
  • 资助金额:
    $ 22.89万
  • 项目类别:
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
4:4 阿片类药物暴露和神经发育的调查 (iOPEN)
  • 批准号:
    10020516
  • 财政年份:
    2019
  • 资助金额:
    $ 22.89万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 22.89万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 22.89万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了